[Therapeutical induced cytochemical changes in acute leukemia].
D000293:Adolescent; D000328:Adult; D000636:Aminosalicylic Acids; D001215:Asparaginase / Q000627:therapeutic use; D001773:Blood Cells / Q000187:drug effects*; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D003630:Daunorubicin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D004950:Esterases; D006651:Histocytochemistry; D006801:Humans; D007938:Leukemia / Q000145:classification / Q000188:drug therapy / Q000201:enzymology*; D004915:Leukemia, Erythroblastic, Acute / Q000201:enzymology; D007945:Leukemia, Lymphoid / Q000201:enzymology; D007948:Leukemia, Monocytic, Acute / Q000201:enzymology; D007951:Leukemia, Myeloid / Q000201:enzymology; D015470:Leukemia, Myeloid, Acute / Q000201:enzymology; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010544:Peroxidases; D011239:Prednisolone / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D010544:Peroxidases; D004950:Esterases; D001215:Asparaginase; D013866:Thioguanine; D008727:Methotrexate; D003630:Daunorubicin
Therapiebedingte Veränderungen zytochemischer Befunde akuter Leukämien.